Harmala alkaloids, also known as harmine or telepathine, are a group of naturally occurring indole-alkaloids derived from the Harmomium plant family. These compounds have gained significant interest due to their potential therapeutic applications, particularly in the treatment of Parkinson's disease and other neurological disorders. Harmala alkaloids exhibit unique bioactivities including anti-inflammatory, antioxidant, and neuroprotective properties. They are characterized by their ability to inhibit monoamine oxidase A (MAO-A), an enzyme that breaks down neurotransmitters such as serotonin, dopamine, and norepinephrine. This inhibition can lead to increased levels of these neurotransmitters in the brain, potentially alleviating symptoms associated with neurological conditions. Research into harmala alkaloids continues to explore their potential as a novel treatment for various diseases, although more clinical studies are needed to fully understand their efficacy and safety profiles. Their use should be closely monitored by medical professionals due to potential side effects and drug interactions.